Fungal Infection in Patients with Diabetes Mellitus.

Author: Na Ra YUN ¹
Author Information

1. Division of Infectious Disease, Department of Internal Medicine, Chosun University School of Medicine, Gwangju, Korea. shine@chosun.ac.kr
Publication Type:Original Article
Keywords: Aspergillosis; Candidiasis; Diabetes mellitus; Fungi; Mucormycosis
MeSH: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Diabetes Mellitus*; Diagnosis; Early Diagnosis; Fluconazole; Fungi; Humans; Mortality; Mucormycosis; Risk Factors; Voriconazole
From:Journal of Korean Diabetes 2017;18(1):20-25
CountryRepublic of Korea
Language:Korean
Abstract: Diabetes mellitus is a major risk factor for fungal infections, and mortality increases when diagnosis and treatment of fungal infections are delayed in diabetic patients. Common fungal infections in diabetic patients are candidiasis, mucormycosis, and aspergillosis. These fungal infections show various clinical manifestations and are treated with various antifungal agents such as fluconazole, echinocandin, amphotericin B, and voriconazole. Early diagnosis and proper treatment are very important when fungal infection is suspected in diabetic patients.